Brian K. Halak is 10% at Orexigen Therapeutics, Inc. (OREX). They have made 27 open-market trades across 11 companies since 2008, most recently 2021-09-17.
CIK 0001354718
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
22 open-market purchases totalling $95.7M since 2008, against 5 sales. Across 6 scored buys the stock is down 3.4% at ninety days, and 3.7 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 0% | 0% |
| Avg Move | -30.0% | -3.4% | -3.4% |
| Alpha | -24.2% | -3.7% | -3.7% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DRNA | SELL | 2018-11-02 | 2018-11-06 | $13.32 | $8.9M | -1.3% | -2.6% | -24.6% |
| DRNA | SELL | 2018-11-01 | 2018-11-01 | $13.37 | $2.5M | +1.2% | +10.7% | -25.8% |
| DRNA | SELL | 2018-10-30 | 2018-11-05 | $13.67 | $13.6M | -6.9% | -4.3% | -25.9% |
| EVOK | SELL | 2015-08-18 | 2015-08-20 | $7.02 | $1K | -20.8% | -0.3% | -0.3% |
| ATRA | BUY | 2014-10-21 | 2014-10-21 | $11.00 | $20K | -24.2% | -6.6% | -6.6% |
| ESPR | BUY | 2014-10-21 | 2014-10-21 | $20.00 | $10.0M | -35.3% | -0.8% | -0.8% |
| OCRX | BUY | 2013-07-15 | 2013-07-25 | $6.03 | $6.0M | N/A | N/A | N/A |
| OCRX | BUY | 2013-07-15 | 2013-07-16 | $6.03 | $2.0M | N/A | N/A | N/A |
| ESPR | BUY | 2013-07-01 | 2013-07-02 | $14.00 | $4.0M | -35.3% | -0.8% | -0.8% |
| CADX | SELL · 10b5-1 | 2013-01-30 | 2013-02-01 | $4.82 | $143K | N/A | N/A | N/A |
| DRTX | BUY | 2012-07-24 | 2012-07-24 | $9.00 | $7.1M | N/A | N/A | N/A |
| OREX | BUY | 2011-12-22 | 2011-12-22 | $1.45 | $680K | N/A | N/A | N/A |
| CLVS | BUY | 2011-11-21 | 2011-11-21 | $13.00 | $12.1M | -29.4% | -2.5% | -2.5% |
| ZGNX | BUY | 2011-09-16 | 2011-09-20 | $2.00 | $7.0M | -27.8% | -4.8% | -4.8% |
| ZGNX | BUY | 2010-11-29 | 2010-12-01 | $4.00 | $9.4M | -27.8% | -4.8% | -4.8% |
| OREX | BUY | 2009-12-17 | 2009-12-21 | $7.54 | $1.0M | N/A | N/A | N/A |
| OREX | BUY | 2009-11-24 | 2009-11-25 | $6.75 | $338K | N/A | N/A | N/A |
| OREX | BUY | 2009-11-20 | 2009-11-24 | $6.93 | $2.8M | N/A | N/A | N/A |
| OREX | BUY | 2009-11-12 | 2009-11-16 | $6.90 | $428K | N/A | N/A | N/A |
| OREX | BUY | 2009-11-10 | 2009-11-12 | $6.93 | $956K | N/A | N/A | N/A |
| OREX | BUY | 2009-08-18 | 2009-08-19 | $7.73 | $107K | N/A | N/A | N/A |
| OREX | BUY | 2009-08-14 | 2009-08-18 | $7.75 | $693K | N/A | N/A | N/A |
| OREX | BUY | 2009-08-12 | 2009-08-14 | $8.00 | $3.3M | N/A | N/A | N/A |
| OREX | BUY | 2009-08-11 | 2009-08-13 | $7.60 | $793K | N/A | N/A | N/A |
| OREX | BUY | 2009-07-23 | 2009-07-24 | $7.50 | $4.9M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| CLVS | 2,990,937 | $243K |
| EVOK | 17,947 | $197K |
| ATRA | 14,049 | $134K |
| VNDA | 7,276 | $29K |
| AKAO | 33,890 | $4K |
| ALIM | 327 | $2K |
| CADX | 2,550,289 | — |
| OREX | 2,967,415 | — |
| OCRX | 988,285 | — |
| VOLC | 56,718 | — |
| DRTX | 3,006,132 | — |
| Total | $456.2M |
Shares reported on the most recent Form 4, priced at the 2021-09-17 close. 5 holdings could not be priced and are excluded from the total.